Amdocs (NASDAQ:DOX) Announces Earnings Results, Beats Estimates By $0.01 EPS

Amdocs (NASDAQ:DOX) posted its earnings results on Wednesday. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01, FiscalAI reports. Amdocs had a net margin of 11.81% and a return on equity of 19.67%. The business had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period last year, the business posted $1.78 EPS. Amdocs’s revenue was up 3.9% compared to the same quarter last year. Amdocs updated its FY 2026 guidance to 7.340-7.480 EPS and its Q3 2026 guidance to 1.810-1.870 EPS.

Here are the key takeaways from Amdocs’ conference call:

• Amdocs reported a solid Q2 revenue of $1.17 billion and non-GAAP EPS of $1.78, both above the midpoint of guidance, with year-over-year growth in North America and record revenue in Europe.
• The company secured several meaningful contract wins and extensions, including expanded managed services with Cricket Wireless, a 5-year CRM/OSS modernization deal with Vodafone Spain, and a multi-year charging system extension with KT.
• Amdocs said its new aOS agentic operating system is getting early traction, with initial commercial agreements from Cricket, Lumen, Bell Canada, EchoStar, and PLDT; PLDT is already seeing over 90% of customer requests resolved through the platform.
• Management reiterated full-year fiscal 2026 guidance, including 3% constant-currency revenue growth at the midpoint and roughly 6% non-GAAP EPS growth, while noting it is still monitoring customer spending amid macro uncertainty.
• Cash generation remained strong, with $97 million in free cash flow before restructuring in Q2 and the company on track for $710 million to $730 million for fiscal 2026, supporting continued shareholder returns and liquidity.

Amdocs Price Performance

NASDAQ:DOX opened at $61.93 on Friday. The company has a 50-day moving average of $65.41 and a 200-day moving average of $73.65. The company has a market capitalization of $6.69 billion, a price-to-earnings ratio of 12.39, a PEG ratio of 1.06 and a beta of 0.40. Amdocs has a 52 week low of $59.40 and a 52 week high of $95.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06.

Amdocs Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date of this dividend is Tuesday, June 30th. Amdocs’s dividend payout ratio (DPR) is presently 44.10%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Amdocs in a research note on Friday, May 8th. Stifel Nicolaus lowered their target price on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research note on Thursday. Cfra lowered shares of Amdocs to a “sell” rating in a research note on Thursday. Barclays decreased their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 4th. Finally, Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, April 18th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $86.67.

Trending Headlines about Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs reported Q2 revenue of $1.17 billion, up 3.9% year over year, and non-GAAP EPS of $1.78, slightly ahead of estimates. Management also raised confidence in the business with fiscal 2026 revenue growth expectations and reiterated strong free cash flow guidance. Article Title
• Positive Sentiment: The company said twelve-month backlog rose to $4.28 billion, suggesting continued demand visibility and supporting expectations for steady medium-term revenue. Article Title
• Positive Sentiment: Amdocs continues to win and expand customer relationships, including a new multi-year agreement with Telefónica Móviles Argentina, a cloud migration effort with Lumen Technologies, and Vodafone Ireland’s go-live on Amdocs network inventory tools. These wins point to ongoing enterprise traction. Article Title
• Positive Sentiment: The company also highlighted AI momentum, including availability of Telco Agents in Google’s Gemini Enterprise Agent Marketplace and a new performance benchmark for its Entitlement Server on Microsoft Azure, reinforcing the investment case around its GenAI pivot. Article Title
• Neutral Sentiment: Amdocs announced its third-quarter 2026 investor conference schedule, which is routine investor-relations activity and not a major operating update. Article Title
• Negative Sentiment: The company’s GAAP operating margin narrowed due to leadership-transition costs, and its shares remain well below the 50-day and 200-day moving averages, suggesting the stock is still working through a longer-term downtrend despite the recent positive results.

Hedge Funds Weigh In On Amdocs

Hedge funds and other institutional investors have recently made changes to their positions in the business. WealthCollab LLC lifted its holdings in shares of Amdocs by 94.5% during the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock worth $29,000 after acquiring an additional 173 shares during the period. Los Angeles Capital Management LLC bought a new position in shares of Amdocs during the 4th quarter worth about $39,000. Advisory Services Network LLC bought a new position in Amdocs during the 3rd quarter valued at about $42,000. CIBC Private Wealth Group LLC lifted its holdings in Amdocs by 190.2% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 595 shares of the technology company’s stock valued at $49,000 after purchasing an additional 390 shares during the last quarter. Finally, Transamerica Financial Advisors LLC lifted its holdings in Amdocs by 146.5% during the 4th quarter. Transamerica Financial Advisors LLC now owns 668 shares of the technology company’s stock valued at $54,000 after purchasing an additional 397 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.